Future advances in the field will rely on the improved identification of functional antibody targets to perturb cancer-relevant signalling, and by the improved selection of tumours that can be effectively treated.

• 该领域的进一步发展将依赖于那些可以扰乱肿瘤相关信号的正常抗体靶位的进一步识别，以及进一步选择那些可以被较好治疗的肿瘤。